Insulin administration using methyl and propyl paraben

Details Insulin administration using methyl and propyl paraben Insulin administration using methyl and propyl paraben

1987-09-10

1988-12-06

Schain, Howard E.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 3, 530303, 530304, 530305, C07K 740, A61K 3726

Patent

active

047896604

ABSTRACT:
A therapeutic composition for trans-mucosal administration in the treatment of diabetes including insulin, as an adjuvant a water-soluble fusidic acid salt and as a co-adjuvant methylparaben and/or propylparaben.

REFERENCES:
patent: 4153689 (1979-05-01), Hirai et al.
patent: 4472385 (1984-09-01), Brange et al.
patent: 4476118 (1984-10-01), Brange et al.
patent: 4548922 (1985-10-01), Carey et al.
patent: 4608364 (1986-08-01), Grau
patent: 4652547 (1987-03-01), Chance et al.
patent: 4701440 (1987-10-01), Grau
Merck Index, 1976, Ninth Ed., pp. 796,1018.

Affiliated with

Also associated with

Rating

Insulin administration using methyl and propyl paraben does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Insulin administration using methyl and propyl paraben, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Insulin administration using methyl and propyl paraben will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1494163